Howie, read Hottod's post clarifying links. This is where I got the charts from too. And Neu only provide a direct link to the Acadia presser on the 10.01.23.
As Hottod has mentioned, the wording is more so a caveat that until FDA approval, Trofinetide can't be assumed to be safe and /or effective (even if the P3 results indicated otherwise). I agree it is somewhat sloppy that Acadia have two different charts dated the same day though. Let's just hope their NDA filing didn't have such discrepancies!.
NEU Price at posting:
$8.03 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)